4th Quarter - Report

WILLIAMS AND JENSEN, PLLC for NOVARTIS INC

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety and drug counterfeiting (track and trace); Drug importation; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; Implementation of the Patient Protection and Affordable Care Act;and drug shortages.

LobbyistCovered position, as disclosed
JENNY DIJAMES LA and LD, Rep. Bud Cramer
JACK STEVEN HART —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH —
MELINDA M MAXFIELD —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax Application of the ACA section 9008 to orphan drugs.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER New Sch. C, Treasury. ; LD Rep. Scott McInnis
GEORGE OLSEN New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare prescription drug benefit. Rebates for Medicare Part D. Independent Payment Advisory Board (IPAB). House and Senate action on H.J. Res. 59 and possible drug industry issues.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
KARINA LYNCH —
ERIN BOOK MULLEN New —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.J.Res. 59 (113th)

Budget/Appropriations BUD

Funding for bioterrorism and pandemic influenza countermeasures.

LobbyistCovered position, as disclosed
MATTHEW B HOEKSTRA —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.